Amarin Corporation plc
http://www.amarincorp.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Amarin Corporation plc
Deal Watch: ICON, PRA Health Form Massive CRO In $12bn Merger
Plus deals involving Sanofi/SIRION, Merck KGAA/Day One, Beijing Tide/Graviton, Vaccinex/Surface Oncology, Athena/Tris, Biomunex/Onward, Cellectis/Cytovia
Brainlab Receives FDA Clearance For Imaging Robot, Alignment Module For Spine
Brainlab is expanding its digital surgery portfolio with the FDA clearance for imaging and alignment module systems.
Tech Transfer Roundup: MD Anderson Tackles Cancer In Alliances With UroGen, Xencor, Obsidian
In tandem with buying the rest of Kleo, Tonix licenses molecular degradation technology from Yale. Neurogene, University of Dundee partner on cell therapies for neurological disorders.
13 New Drugs Pass Muster At The EMA, Dexamethasone Withdrawal Explained
New products from Paion, Arvelle, Incyte and many others have been recommended for approval by the European Medicines Agency. Meanwhile, the agency has explained why the EU marketing authorization application for Dexamethasone Taw, for treating COVID-19 patients, was withdrawn.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Amarin Pharma
- Amarin Pharmaceuticals Ireland Limited
- Laxdale Limited